Mihail "Misha" Zilbermint, MD, MBA

Associate Professor @hopkinsmedicine & @GWSMHS| Director of #EndocrineHospitalists | Chief of #Endocrinology @SuburbanHosp | Endocrinology Expert Witness

[Endocrine Today @EndocrineToday]

💡 Tips for initiating #CGM prior to hospital discharge, according to @zilbermint at @hopkinsmedicine

📌 Train hospital nurses on how to use #diabetes technology
📌 Be inclusive while also respecting a patient’s interest in using a CGM

@GoHealio

https://t.co/rETrhgteNY

[Hopkins Med News @HopkinsMedNews]

New @HopkinsMedicine protocol shows how hospitals can safely start continuous glucose monitoring (#CGM) at discharge—improving patient education & outcomes. @SageJournals https://t.co/o2KuLmlKex.

[Endocrine Today @EndocrineToday]

🏥Starting a CGM during hospitalization could offer several benefits for patients with #diabetes.

@GoHealio spoke with @zilbermint about how hospitals can train staff and set up a plan to initiate CGM for patients as they are preparing to discharge.

https://t.co/rETrhgteNY

[Mihail "Misha" Zilbermint, MD, MBA @zilbermint]

It is thrilling to see the new oral #obesity #GLP-1 drugs making their way into the U.S. market. A key question remains: what will the #cost be, and how will accessibility be addressed? https://t.co/prNcBcZj0k

[Endocrine News @Endocrine_News]

Check out @TheEndoSociety's 2023 Clinical Practitioner Laureate Award recipient @zilbermint discussing @EliLillyandCo's new #obesity pill:

https://t.co/YnnXxvCZwO

[Hopkins Med News @HopkinsMedNews]

.@HopkinsMedicine endocrinologist @zilbermint discusses how Eli Lilly's obesity pill could be a game changer for patients. @CNBC
https://t.co/Yj8KapydRA

[Endocrine Today @EndocrineToday]

📱 MARD values between CGM and other #glucose measurement methods are not associated with laboratory values or vital signs, which provides “reassurance regarding the use of CGMs in the hospital setting."

@MayoClinic @zilbermint

https://t.co/C1UE87RUhl

[Hopkins Med News @HopkinsMedNews]

“We need to treat prediabetes as an actual diagnosis — not just a warning sign.” says @HopkinsMedicine endocrinologist @zilbermint.
From Screening to Intervention: Optimizing Prediabetes Care in Primary Care Settings. @Medscape
https://t.co/rh1iB3fLI6

[Endocrine Today @EndocrineToday]

📣 "CGMs brought from home demonstrated strong accuracy across a diverse hospitalized population, with more than 98% of values in clinically acceptable error grid zones."

@MayoClinic @zilbermint #diabetes #glucose

https://t.co/C1UE87RUhl

[Mihail "Misha" Zilbermint, MD, MBA @zilbermint]

What a wonderful collaboration! Thanks to @TheAACE for the invitation to join the effort!

[Vin Tangpricha, MD, PhD @vtangpricha]

New Guidelines on Lipids! American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia @TheAACE #EndocrinePractice #EndoTwitter #LabmedTwitter https://t.co/Gje8PRzOgn

[AACE @TheAACE]

A summary of the updated @AmDiabetesAssn consensus report on hyperglycemic crisis management, which has been endorsed jointly by AACE, @EASDnews, @JBDSIP, @DiabetesTechSoc. Read more: https://t.co/12PvPg9Wqz @Els_ENDO @vtangpricha #endocrinology

[AACE @TheAACE]

A summary of the updated @AmDiabetesAssn consensus report on hyperglycemic crisis management, which has been endorsed jointly by AACE, @EASDnews, @JBDSIP, @DiabetesTechSoc. Read more: https://t.co/12PvPg9Wqz @Els_ENDO @vtangpricha #endocrinology

[Mihail "Misha" Zilbermint, MD, MBA @zilbermint]

Just published a new case report in @TheAACE #ClinicalCaseReports! It highlights the successful use of hyperinsulinemic-euglycemic therapy for severe calcium channel blocker overdose. https://t.co/0BDCka8Eha

[Mihail "Misha" Zilbermint, MD, MBA @zilbermint]

#CMS will hold hospitals accountable for not reporting poor #glycemic outcomes. Will this make our hospitals safer for people living with #diabetes? https://t.co/MxXMsnM6yC

[Mihail "Misha" Zilbermint, MD, MBA @zilbermint]

@SamanehDowlat @HMethodistMD @MethodistHosp @AshRasool20 Brilliant, simple and straightforward tool for all residents and endocrinology fellows. @Els_ENDO @EndoHopkins @HopkinsMedicine

[Samaneh Dowlatshahi, MD, FACE,FACP @SamanehDowlat]

Excited to share the publication of our new book chapter new insights/ insulin and non-insulin approaches based on most recent guidelines.
Inpatient management of type 2 diabetes. Special thanks to @zilbermint for this opportunity. @HMethodistMD @MethodistHosp @AshRasool20

[Rifka Schulman-Rosenbaum, MD, FACE, FACP @RifkaSchulmanMD]

Q&A: New guidance for monitoring pre-symptomatic type 1 diabetes https://t.co/6IrgTMmb4n @BreakthroughT1D @TheAACE @DiabetesCareADA @ADA_Pubs @HofNorthwellDOM @YTobiHarris

[Vin Tangpricha, MD, PhD @vtangpricha]

New commentary on the ADA guidelines on DKA #EndocrinePractice by Drs Swapnil Khare, Garg, Shah and @zilbermint Navigating the New Frontiers of Hyperglycemic Crisis Management: Unveiling the Latest American Diabetes Association Consensus Report https://t.co/hwMhgCJ7Sd

[Mihail "Misha" Zilbermint, MD, MBA @zilbermint]

🚀 Exciting News! Our #EndocrineHospitalist team just published "Inpatient #Diabetes Management" in @NYASciences! @HopkinsMedicine @HopkinsHowardC @sibleyonline @SuburbanHosp @EndoHopkins

https://t.co/5mXBmEHCZ1

[Mihail "Misha" Zilbermint, MD, MBA @zilbermint]

Great piece by @MiriamETucker from @Medscape about the timing of #insulin administration in the #hospital and hypoglycemia reduction.
https://t.co/y4PqmqYgOe